Sanofi (EPA:SAN)

Exscientia Statistics

Total Valuation

Sanofi has a market cap or net worth of EUR 96.04 billion. The enterprise value is 103.24 billion.

Market Cap	96.04B
Enterprise Value	103.24B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	May 12, 2025

Share Statistics

Sanofi has 1.22 billion shares outstanding. The number of shares has decreased by -0.95% in one year.

Current Share Class	1.22B
Shares Outstanding	1.22B
Shares Change (YoY)	-0.95%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	59.30%
Float	1.10B

Valuation Ratios

The trailing PE ratio is 15.32 and the forward PE ratio is 9.51. Sanofi's PEG ratio is 0.93.

PE Ratio	15.32
Forward PE	9.51
PS Ratio	2.10
PB Ratio	1.37
P/TBV Ratio	10.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.93

Enterprise Valuation

EV / Earnings	11.31
EV / Sales	2.26
EV / EBITDA	8.12
EV / EBIT	10.35
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.

Current Ratio	1.27
Quick Ratio	0.54
Debt / Equity	0.32
Debt / EBITDA	1.78
Debt / FCF	n/a
Interest Coverage	23.40

Financial Efficiency

Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.47%.

Return on Equity (ROE)	9.00%
Return on Assets (ROA)	4.81%
Return on Invested Capital (ROIC)	6.47%
Return on Capital Employed (ROCE)	10.23%
Revenue Per Employee	551,871
Profits Per Employee	110,114
Employee Count	82,878
Asset Turnover	0.36
Inventory Turnover	n/a

Taxes

In the past 12 months, Sanofi has paid 1.54 billion in taxes.

Income Tax	1.54B
Effective Tax Rate	19.24%

Stock Price Statistics

The stock price has decreased by -15.72% in the last 52 weeks. The beta is 0.40, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-15.72%
50-Day Moving Average	84.92
200-Day Moving Average	94.27
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	1,802,088

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of EUR 45.74 billion and earned 9.13 billion in profits. Earnings per share was 7.35.

Revenue	45.74B
Gross Profit	32.63B
Operating Income	9.81B
Pretax Income	7.99B
Net Income	9.13B
EBITDA	12.23B
EBIT	9.81B
Earnings Per Share (EPS)	7.35

Balance Sheet

The company has 15.36 billion in cash and 22.29 billion in debt, giving a net cash position of -6.93 billion or -5.69 per share.

Cash & Cash Equivalents	15.36B
Total Debt	22.29B
Net Cash	-6.93B
Net Cash Per Share	-5.69
Equity (Book Value)	70.28B
Book Value Per Share	57.52
Working Capital	7.96B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 71.34%, with operating and profit margins of 21.44% and 19.95%.

Gross Margin	71.34%
Operating Margin	21.44%
Pretax Margin	17.46%
Profit Margin	19.95%
EBITDA Margin	26.75%
EBIT Margin	21.44%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3.92, which amounts to a dividend yield of 4.97%.

Dividend Per Share	3.92
Dividend Yield	4.97%
Dividend Growth (YoY)	4.26%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.95%
Shareholder Yield	5.53%
Earnings Yield	9.50%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4